(October 20, 2017) An international, large scale study may have found a link between high-grade ovarian cancer and a type of white blood cell known as a tumor-infiltrating lymphocyte. Recently published in JAMA Oncology, the article from the Ovarian Tumor Tissue Analysis Consortium discussed the study, which involved about 5,500 patients, 3,196 of whom had high-grade ovarian cancer. Although it was previously established that high grade ovarian cancer tumors contain cyctotoxic CD8, a type of tumor infiltrating lymphocyte, the study found a direct correlation between the levels of CD8 and survival: the higher the CD8 level, the better the survival for patients. Show “Developing a better understanding of factors that increase cytotoxic CD8 tumor-infiltrating lymphocytes will be the key to developing treatments to achieve better outcomes in treating patients with high-grade ovarian cancer,” concludes Matthew Block, MD, PhD, co leader of the team at Mayo Clinic. Share this pageMore StoriesPrev: OCRFA Funded Study Discovers 3 Key Genes in Prevention and Treatment of BRCA1 and BRCA2 Tumors Next: New Research Indicates that High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tubes C.C. C.C. Gunderson Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of
Gynecologic Oncology, Oklahoma City, OK, USA K.N. Slaughter K.N. Slaughter Affiliations University of Oklahoma
Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author E.D. Thomas E.D. Thomas Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author R. Farrell R. Farrell Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author K. Ding K. Ding Affiliations The University of Oklahoma Health Sciences Center, College of Public Health, Department of Biostatistics and Epidemiology, Oklahoma City, OK, USA Search for articles by this author J.K. Lauer J.K. Lauer Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author L.J. Perry L.J. Perry Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author D.S. McMeekin D.S. McMeekin Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author K.N. Moore K.N. Moore Affiliations University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA Search for articles by this author Objectives: Thrombocytosis (TBC) is often a marker of occult malignancy and is a poor prognostic factor in ovarian cancer. Shorter time to progression, decreased overall survival, and advanced stage disease have been
noted with TBC. Preoperative leukocytosis (LC) has been shown to be an independent poor prognostic factor in carcinoma of the cervix and endometrium; however, the prognosis of LC with ovary cancer is less clear. To read this article in full you will need to make a payment DOI:
https://doi.org/10.1016/j.ygyno.2013.07.042 © 2013 Published by Elsevier Inc. Can you have cancer with a low white blood cell count?Why It Occurs. A person with cancer can develop a low WBC count from the cancer or from treatment for the cancer. Cancer may be in the bone marrow, causing fewer neutrophils to be made. The WBC count can also go down when cancer is treated with chemotherapy drugs, which slow bone marrow production of healthy WBCs.
Does ovarian cancer affect blood count?If your level is high, it is a sign that there is some kind of problem and you will need to have further tests. The CA125 blood level is raised in around half of women who have early stage ovarian cancer. Almost 90 out of 100 women (90%) with more advanced ovarian cancer have raised CA125 levels.
Does cancer show up in white blood cell count?Not always. A high white blood cell count could signal certain types of cancer, such as leukemia or lymphoma, but it more often is a sign of inflammation or infection.
What happens when a cancer patient white blood cells are low?Infection. With a low white blood cell count and, in particular, a low level of neutrophils, you're at higher risk of developing an infection. And if you develop an infection when you have a low white blood cell count, your body can't protect itself. Infection can lead to death in severe cases.
|
Ovarian cancer low white blood cell count
Related Posts
Copyright © 2024 paraquee Inc.
